Canaccord is Bullish on Aurora Cannabis Inc. (ACB)

Aurora Cannabis Inc. (NASDAQ:ACB) is among the 7 Best Cannabis Stocks to Invest In Now.

Aurora Cannabis Inc. (NASDAQ:ACB) is among the Best Marijuana Stocks. 

Based on a Feb. 5, 2026, TheFly report, Canaccord reduced its price target for Aurora Cannabis Inc. (NASDAQ:ACB) from C$10 to C$9. It kept the shares at a Buy rating.

In the third quarter of fiscal 2026, Aurora Cannabis Inc. (NASDAQ:ACB) Cannabis reported a 7% year-over-year growth in total net sales, reaching $94.2 million. Germany and Poland topped the global growth in medical cannabis net sales, which rose 12% to a record $76.2 million. Free cash flow came to $15.5 million, adjusted net income to $7.2 million, and adjusted EBITDA to $18.5 million. The corporation announced a debt-free cannabis business at the conclusion of the quarter, with $154.4 million in cash and short-term investments. The management noted their leadership in genetics, GMP production, global medicinal cannabis, operational efficiency, regulatory knowledge, and prospective M&A possibilities. Chief Executive Officer Miguel Martin remarked that the firm's results show a concentrated strategy focusing on medical cannabis and trust in its future performance.

Aurora Cannabis Inc. (NASDAQ:ACB) produces, distributes, and sells cannabis and products derived from cannabis. It functions through the Plant Propagation and Cannabis divisions.

While we acknowledge the potential of ACB as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 20 Best AI Stock To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None.